Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03836352
Title Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ImmunoVaccine Technologies, Inc. (IMV Inc.)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
The University of Arizona Cancer Center Tucson Arizona 58724 United States Details
Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles California 90048 United States Details
Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton Florida 33486 United States Details
Hematology Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34952 United States Details
Comprehensive Hematology and Oncology Saint Petersburg Florida 33709 United States Details
Winship Cancer Institute: The Emory Clinic Atlanta Georgia 30322 United States Details
James Brown Graham Cancer Center:University of Louisville Hospital Louisville Kentucky 40202 United States Details
Ochsner Cancer Institute New Orleans Louisiana 70121 United States Details
Allina Health, Virginia Piper Cancer Institute Minneapolis Minnesota 55407 United States Details
Christus St. Vincent Regional Cancer Center Santa Fe New Mexico 87505 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
NYU Winthrop Hospital Mineola New York 11501 United States Details
University of Toledo Toledo Ohio 43614 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
MD Anderson Houston Texas 77030 United States Details
William Osler Health System Brampton Ontario L6R3J7 Canada Details
Juravinski Cancer Center Hamilton Ontario L8V 5C2 Canada Details
Southlake Regional Health Center Newmarket Ontario L3Y 2P9 Canada Details
The Ottawa Hospital Ottawa Ontario K1H 8L6 Canada Details
Sunnybrook Research Institute Toronto Ontario Canada Details
Centre hospitalier de l'Université de Montréal (CHUM) Montreal Quebec H2X 0A9 Canada Details
McGill University Health Center Montreal Quebec H4A 3J1 Canada Details
CHU de Québec-Université Laval Québec Quebec G1R 2J6 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field